Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes

Clinical Science

Volumn 131, Issue 15, 2017, Pages 1905-1917

  Brouwers, Bram ^a,b   Schrauwen Hinderling, Vera B ^a,b   Jelenik, Tomas ^c   Gemmink, Anne ^a,b   Havekes, Bas ^a,b   Bruls, Yvonne ^a,b   Dahlmans, Dennis ^a,b   Roden, Michael ^c,d   Hesselink, Matthijs K C ^a,b   Schrauwen, Patrick ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AEROBIC CAPACITY; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FITNESS; GLUCONEOGENESIS; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; BLOOD; ENZYMOLOGY; GLUCOSE CLAMP TECHNIQUE; LIPID METABOLISM; LIVER; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; SKELETAL MUSCLE;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 85023640817     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20170261     Document Type: Article

References (50)

1. Caldwell, S. and Argo, C. (2010) The natural history of non-alcoholic fatty liver disease. Dig. Dis. 28, 162-168
2. Tilg, H., Moschen, A.R. and Roden, M. (2017) NAFLD and diabetes mellitus. Nature Reviews. Gastroenterol. Hepatol. 14, 32-42
3. Firneisz, G. (2014) Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? World J. Gastroenterol. 20, 9072-9089
4. Utzschneider, K.M. and Kahn, S.E. (2006) Review: The role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 91, 4753-4761
5. Yki-Jarvinen, H. (2010) Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig. Dis. 28, 203-209
6. Ortiz-Lopez, C., Lomonaco, R., Orsak, B., Finch, J., Chang, Z., Kochunov, V.G. et al. (2012) Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care 35, 873-878
7. Suh, S.Y., Choi, S.E., Ahn, H.Y., Yang, H.M., Kim, Y.I. and Sung, N.J. (2009) The association between normal alanine aminotransferase levels and the metabolic syndrome: 2005 Korean National Health and Nutrition Examination Survey. Metabolism 58, 1731-1736
8. Ioannou, G.N., Weiss, N.S., Boyko, E.J., Kahn, S.E. and Lee, S.P. (2005) Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease. Gastroenterology 128, 627-635
9. Korenblat, K.M., Fabbrini, E., Mohammed, B.S. and Klein, S. (2008) Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134, 1369-1375
10. Koska, J., Stefan, N., Permana, P.A., Weyer, C., Sonoda, M., Bogardus, C. et al. (2008) Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am. J. Clin. Nutr. 87, 295-302
11. Hwang, J.H., Stein, D.T., Barzilai, N., Cui, M.H., Tonelli, J., Kishore, P. et al. (2007) Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am. J. Physiol. Endocrinol. Metab. 293, E1663-1669
12. Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R. et al. (2007) Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133, 496-506
13. Roden, M. (2006) Mechanisms of Disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nature clinical practice. Endocrinol. Metab. 2, 335-348
14. Kato, K., Takamura, T., Takeshita, Y., Ryu, Y., Misu, H., Ota, T. et al. (2014) Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease. PLoS ONE 9, e92170
15. Fabbrini, E., Magkos, F., Mohammed, B.S., Pietka, T., Abumrad, N.A., Patterson, B.W. et al. (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U.S.A. 106, 15430-15435
16. Deivanayagam, S., Mohammed, B.S., Vitola, B.E., Naguib, G.H., Keshen, T.H., Kirk, E.P. et al. (2008) Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am. J. Clin. Nutr. 88, 257-262
17. Lomonaco, R., Ortiz-Lopez, C., Orsak, B., Webb, A., Hardies, J., Darland, C. et al. (2012) Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 55, 1389-1397
18. Szendroedi, J., Zwettler, E., Schmid, A.I., Chmelik, M., Pacini, G., Kacerovsky, G. et al. (2008) Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly. PLoS ONE 3, e3958
19. Phielix, E., Schrauwen-Hinderling, V.B., Mensink, M., Lenaers, E., Meex, R., Hoeks, J. et al. (2008) Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 57, 2943-2949
20. Mohd Nor, N.S., Lee, S., Bacha, F., Tfayli, H. and Arslanian, S. (2016) Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr. Diab. 17, 458-465
21. Kuipers, H., Verstappen, F.T., Keizer, H.A., Geurten, P. and van Kranenburg, G. (1985) Variability of aerobic performance in the laboratory and its physiologic correlates. Int. J. Sports Med. 6, 197-201
22. Bilet, L., Brouwers, B., van Ewijk, P.A., Hesselink, M.K., Kooi, M.E., Schrauwen, P. et al. (2015) Acute exercise does not decrease liver fat in men with overweight or NAFLD. Sci. Rep. 5, 9709
23. Lindeboom, L., Nabuurs, C.I., Hesselink, M.K., Wildberger, J.E., Schrauwen, P. and Schrauwen-Hinderling, V.B. (2015) Proton magnetic resonance spectroscopy reveals increased hepatic lipid content after a single high-fat meal with no additional modulation by added protein. Am. J. Clin. Nutr. 101, 65-71
24. Guiu, B., Petit, J.M., Loffroy, R., Ben Salem, D., Aho, S., Masson, D. et al. (2009) Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 250, 95-102
25. Szczepaniak, L.S., Nurenberg, P., Leonard, D., Browning, J.D., Reingold, J.S., Grundy, S. et al. (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 288, E462-E468
26. DeFronzo, R.A., Tobin, J.D. and Andres, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237, E214-E223
27. van de Weijer, T., Phielix, E., Bilet, L., Williams, E.G., Ropelle, E.R., Bierwagen, A. et al. (2015) Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. Diabetes 64, 1193-1201
28. Finegood, D.T., Bergman, R.N. and Vranic, M. (1987) Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36, 914-924
29. Ackermans, M.T., Pereira Arias, A.M., Bisschop, P.H., Endert, E., Sauerwein, H.P. and Romijn, J.A. (2001) The quantification of gluconeogenesis in healthy men by (2)H2O and [2-(13)C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with (2)H2O are higher than those measured with [2-(13)C]glycerol. J. Clin. Endocrinol. Metab. 86, 2220-2226
30. Steele, R. (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann. N.Y. Acad. Sci. 82, 420-430
31. Peronnet, F. and Massicotte, D. (1991) Table of nonprotein respiratory quotient: an update. Can. J. Sport Sci. 16, 23-29
32. Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502
33. Sondergaard, E., Espinosa De Ycaza, A.E., Morgan-Bathke, M. and Jensen, M.D. (2017) How to Measure Adipose Tissue Insulin Sensitivity. J. Clin. Endocrinol. Metab. 102, 1193-1199
34. Rosso, C., Mezzabotta, L., Gaggini, M., Salomone, F., Gambino, R., Marengo, A. et al. (2016) Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease. Hepatology 63, 107-116
35. Maximos, M., Bril, F., Portillo Sanchez, P., Lomonaco, R., Orsak, B., Biernacki, D. et al. (2015) The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease. Hepatology 61, 153-160
36. van den Berg, E.H., Amini, M., Schreuder, T.C., Dullaart, R.P., Faber, K.N., Alizadeh, B.Z. et al. (2017) Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: a large Dutch population cohort. PLoS ONE 12, e0171502
37. Sattar, N., Forrest, E. and Preiss, D. (2014) Non-alcoholic fatty liver disease. BMJ 349, g4596
38. Wroblewski, F. (1958) The clinical significance of alterations in transaminase activities of serum and other body fluids. Adv. Clin. Chem. 1, 313-351
39. Browning, J.D., Szczepaniak, L.S., Dobbins, R., Nuremberg, P., Horton, J.D., Cohen, J.C. et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387-1395
40. Portillo-Sanchez, P., Bril, F., Maximos, M., Lomonaco, R., Biernacki, D., Orsak, B. et al. (2015) High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. J. Clin. Endocrinol. Metab. 100, 2231-2238
41. Koplay, M., Sivri, M., Erdogan, H. and Nayman, A. (2015) Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease. World J. Hepatol. 7, 769-776
42. Tamura, Y., Watada, H., Sato, F., Kumashiro, N., Sakurai, Y., Hirose, T. et al. (2008) Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects. Diabetes Obes. Metab. 10, 733-738
43. Seppala-Lindroos, A., Vehkavaara, S., Hakkinen, A.M., Goto, T., Westerbacka, J., Sovijarvi, A. et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87, 3023-3028
44. Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S. et al. (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48, 634-642
45. Gastaldelli, A., Harrison, S.A., Belfort-Aguilar, R., Hardies, L.J., Balas, B., Schenker, S. et al. (2009) Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 50, 1087-1093
46. Gastaldelli, A., Gaggini, M. and DeFronzo, R.A. (2017) Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio Metabolism Study. Diabetes 66, 815-822
47. Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R.A., Bugianesi, E. and Gastaldelli, A. (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5, 1544-1560
48. Kotronen, A., Juurinen, L., Tiikkainen, M., Vehkavaara, S. and Yki-Jarvinen, H. (2008) Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 135, 122-130
49. Kelley, D.E. and Mandarino, L.J. (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49, 677-683
50. Bril, F., Barb, D., Portillo-Sanchez, P., Biernacki, D., Lomonaco, R., Suman, A. et al. (2017) Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology 65, 1132-1144